We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Treatt Plc | LSE:TET | London | Ordinary Share | GB00BKS7YK08 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
29.00 | 5.97% | 515.00 | 506.00 | 510.00 | 510.00 | 483.00 | 494.50 | 160,518 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 147.4M | 10.94M | 0.1802 | 28.14 | 295.11M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/12/2024 19:15 | What's with the weird bump today? | viscount1 | |
20/12/2024 18:38 | Thanks for posting that | niklol | |
20/12/2024 18:38 | Thanks for posting that | niklol | |
19/12/2024 10:56 | Shares magazine this week has included Treatt as one of its 10 great picks for 2025. There is a very encouraging and positive 2 page report in the magazine. | truffle | |
13/12/2024 13:04 | Hi EI, I had initially planned to hold for a while, but ANCR, a company I've followed for years, made a transformative acquisition. This prompted me to sell TET and shift my focus to ANCR. | simon gordon | |
13/12/2024 12:47 | justice, off topic - your best hope with SN is a bid approach. I'm 57 next year and back when I was 19, SN was frequently referenced as a bid target. Here we are decades later..(may still happen). Smith and Nephew is no where near the same quality of Stryker, they arguably should not be mentioned in the same breath. | essentialinvestor | |
13/12/2024 12:45 | Simon, I'm guessing you exited, I hope you reaped a gain. If anyone wants a potential bearish take, the complete lack of any BOD buying post results, might be worth noticing. | essentialinvestor | |
12/12/2024 08:00 | Sold yesterday | zam1 | |
11/12/2024 14:37 | Holding but why can't this keep its gains? | justiceforthemany | |
11/12/2024 10:13 | Simon, we remain (for now) in the same trading range, approx £4-£5. TET has bounced from under £4, and the lower £4's multiple times now. I mentioned this the week before results. | essentialinvestor | |
11/12/2024 09:53 | Citywire - 11/12/24: Treatt targets look tough, says Deutsche Deutsche Bank is expecting ingredients group Treatt (TET) to fall short of its premium ambitions over the coming years. Analyst Deirdre Mullaney retained her ‘hold’ recommendation and target price of 500p on the stock, which gained 3.2% to 490p yesterday. ‘We think management’s ambition to deliver two-thirds of revenue from its premium segment, from 25%, as likely to fall beyond our forecast period,’ Mullaney said. ‘We estimate that it could achieve 40% of sales from premium if the segment delivered 20% within five years, but that would be over twice as fast as our current forecasts for 9% growth.’ She said that she had ‘some reservations around underlying growth momentum into next year’ but expected ‘better visibility’ at the annual general meeting update in January. ‘Our unchanged price target of 500p indicates 8% potential total return upside,’ she explained. | simon gordon | |
08/12/2024 15:02 | Not much IP but a lot of know how is my take . If they can get factory utilisation up to 80% + in the next year or so - we will be rocking | edwardt | |
06/12/2024 19:00 | Very nice week. | essentialinvestor | |
06/12/2024 15:43 | I had a look at the preliminary results. Impressive cash flow and cost control to get net debt to near zero. I find it hard to judge how much of an economic moat they have though. On the one hand they seem quite niche in their manufacturing capability, which is good, but unless they have a lot of IP then that could be replicated quite easily (particularly in China). The upside on such a small company is substantial, although it will probably only be realized if they get bought out by a competitor (or a big customer). | viscount1 | |
05/12/2024 16:13 | Maybe the copied Simply Wall Street. They have target just over 9 pounds | muffster | |
05/12/2024 13:20 | Peel Hunt are their house brokers so hard to take too seriously. | viscount1 | |
05/12/2024 12:50 | Citywire - 5/12/24: ‘Buy’ Treatt, says Peel Hunt Ingredients and flavourings group Treatt (TET) is trading at a significant discount to peers but Peel Hunt believes it will soon start to narrow. Analyst Charles Hall reiterated his ‘buy’ recommendation and target price of 800p on the stock, which gained 6.1% to 456p on Wednesday. Full-year results from the group came in as expected with sales of £153m, £2m below the previously announced £155m as a hurricane delayed a shipment. Profit before tax was as expected at £19.1m. ‘The valuation gap to peers is still significant, and we expect it to narrow materially as confidence in the outlook improves,’ said Hall. ‘Treatt has more than 50% spare capacity and numerous growth opportunities ahead.’ Hall added that the company was ‘very well invested’ and has ‘strategic value’. | simon gordon | |
04/12/2024 18:27 | Are they doing any EOY presentations? | deanowls | |
04/12/2024 15:39 | 2 months into the year and all is clearly going well | phillis | |
04/12/2024 14:41 | Indeed, surprised Mr Market got this so wrong and a recent rare well timed purchase | rimau1 | |
04/12/2024 12:26 | It was fleetingly available on the offer at just below £4, literally for a few seconds. | essentialinvestor | |
04/12/2024 11:03 | I thought a significant move was on the cards as mentioned over the weekend. | essentialinvestor | |
04/12/2024 09:34 | Red to green, what a turnaround | mrbeaky | |
04/12/2024 09:16 | Pension .5m to come out, 2million exceptional s for a warehouse move?, finance costs to reduce, a large order to go into q1 and soft compatibles for H1 last year. Anyone any idea what land and buildings they own that are valued at cost? A lot to like going forward. | deanowls | |
04/12/2024 08:52 | The offer price just before yesterday's close was £4.08, currently £4.20 - all be it is moving around a lot. | essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions